BBLG (Bone Biologics) Insider Ownership: 97.28 % (As of Sep. 14, 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

BBLG Bone Biologics Corp BBLG
30 GF Score
Price $0.54
! 1 Warning Sign
View Full Analysis

What is Bone Biologics Insider Ownership?

Bone Biologics BBLG -1.94% 30 Insider Ownership is 97.28 % as of Sep. 14, 2026. GuruFocus rates BBLG with a GF Score™ of 30/100. The stock has 1 warning sign investors should review.

Insider ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Bone Biologics's insider ownership is 97.28%.

Institutional Ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Bone Biologics's Institutional Ownership is 1.44%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Bone Biologics's Float Percentage Of Total Shares Outstanding is 99.83%.

Bone Biologics Insider Ownership Historical Data

* Premium members only.

The historical data trend for Bone Biologics's Insider Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Bone Biologics Insider Ownership Chart

Bone Biologics Historical Data

The historical data trend for Bone Biologics can be seen below:

2022-08-31 2022-09-30 2022-10-31 2022-11-30 2022-12-31 2023-01-31 2023-02-28 2023-03-31 2023-04-30 2023-11-30
Insider Ownership 39.85 39.85 29.20 26.96 26.96 26.96 26.96 24.70 24.70 97.28
BBLG
30GF Score
Bone Biologics Corp BBLG
Insider Ownership is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Bone Biologics Insider Ownership Calculation

The percentage of shares that are owned by company insiders relative to the total shares outstanding.

Frequently Asked Questions Learn more about Insider Ownership →
What does a Insider Ownership of 97.28 % mean?
Bone Biologics (BBLG) has a Insider Ownership of 97.28 % as of Sep. 14, 2026. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bone Biologics and its competitors.
Is Bone Biologics' Insider Ownership too high?
Bone Biologics' current Insider Ownership is 97.28 %. Overall, Bone Biologics has a GF Score™ of 30/100, reflecting its overall financial health beyond just this single metric.
How does Bone Biologics' Insider Ownership compare to SCNI and ATXI?
Bone Biologics' Insider Ownership of 97.28 % can be compared against companies in the Biotechnology industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Insider Ownership for a Biotechnology company?
A good Insider Ownership depends on the Biotechnology industry context. However, Insider Ownership should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Insider Ownership mean?
A high Insider Ownership can signal that a stock is expensive relative to its fundamentals. Insider ownership equals the percent of shares owned by company insiders relative to total shares. View historical data on Bone Biologics and its competitors. Bone Biologics's current Insider Ownership is 97.28 %. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Bone Biologics stock overvalued right now?
Bone Biologics (BBLG) has a current Insider Ownership of 97.28 %. The current Insider Ownership is 97.28 %. Bone Biologics' overall GF Score™ is 30/100 with 1 warning sign to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Insider Ownership calculated?
Insider Ownership is calculated from a company's financial statements. For Bone Biologics (BBLG), the current Insider Ownership is 97.28 % as of Sep. 14, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Bone Biologics Business Description

Address 2 Burlington Woods Drive, Suite 100, Burlington, MA, USA, 01803
Bone Biologics Corp a medical device company that is currently focused on bone regeneration in spinal fusion using the recombinant human protein known as NELL-1. NELL-1 in combination with DBM, demineralized bone matrix, is an osteopromotive recombinant protein that provides target specific control over bone regeneration. It is a clinical-stage entity. The production and marketing of its products and ongoing research and development activities are subject to extensive regulation by numerous governmental authorities in the United States.
30GF Score

Get the complete analysis for BBLG

Insider Ownership is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.54
Price